Peri-implantitis Market Trends

  • Report ID: 3922
  • Published Date: Dec 20, 2024
  • Report Format: PDF, PPT

Peri-implantitis Sector: Growth Drivers and Challenges

Growth Drivers

  • Growing Consumption of Cigarette – cigarette is the most dangerous substance when it comes to oral health. Various studies across the world have shown that smokers who had dental implants were most likely to get peri-implantitis. Smoking habits can harm surgically placed implants. For instance, it was estimated that more than 38 million adults in the United States smoke cigarettes while around 7 million people lost their lives owing to tobacco consumption in 2020.

  • Rising Geriatric Population – Elderly population is more prone to peri-implantitis since it has been observed that people aged 65 and above are independently associated with peri-implantitis. Based on the data released by the World Health Organization (WHO) 1 out of 6 people is expected to be aged 60 and above by 2030.

  • Increasing Awareness of Oral Care – oral health is the most necessary step to avoid since it can be caused by several oral diseases. As of 2022, more than 3 billion people were projected to live with oral diseases across the globe. Meanwhile, every 1 in 4 adults in the USA is projected to have untreated cavities.

  • Growing Incidences of Periodontal Disease – the higher prevalence of periodontal disease across the globe is also anticipated to hike the market growth over the forecast period. For instance, the prevalence of periodontal disease is so high that it was anticipated that more than 85% of people are projected to experience periodontal disease once in a lifetime across the globe.

Challenges

  • Difficult Diagnosis of Peri-implantitis

The diagnosis of peri-implantitis is quite difficult since, for several years, it grows in the gums silently. It becomes difficult to distinguish the reason for bone decaying if it is due to bone remodeling and or infection. Most people are not even aware of the treatment. Therefore, this factor is estimated to hamper the growth of the market over the forecast period.

  • Lack of Awareness regarding the Disease
  • Higher Cost Associated with Peri-implantitis

Base Year

2024

Forecast Year

2025-2037

CAGR

7.9%

Base Year Market Size (2024)

USD 2.33 billion

Forecast Year Market Size (2037)

USD 6.26 billion

Regional Scope

  • North America (U.S., and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of peri-implantitis is estimated at USD 2.63 billion.

The peri-implantitis market size was valued at USD 2.33 billion in 2024 and is likely to cross USD 6.26 billion by 2037, registering more than 7.9% CAGR during the forecast period i.e., between 2025-2037. Growing consumption of cigarettes and increasing awareness of oral care will boost the market growth.

Asia Pacific industry is expected to hold largest revenue share by 2037, attributed to increasing prevalence of oral diseases, along with rising awareness regarding oral health.

The major players in the market are Aetna Inc., Pfizer Inc., Cadila Pharmaceuticals Limited, R N Laboratories Pvt Ltd, Neoss Limited, Basic Pharma Lifesciences Pvt Ltd, Dawood and Tanner, Prachi Pharmaceuticals Private Limited, Geistlich Pharma AG., Healthy Life Pharma Private Limited.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos